RIGL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Rigel Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 40.76 USD -2.18%

Market Cap: $754.1m

	Rigel Pharmaceuticals Inc NASDAQ:RIGL	US
T	Texas Instruments Inc XBER:TII	US
	Solstad Maritime ASA F:O6O	NO
	Urban Outfitters Inc NASDAQ:URBN	US
	Platinum Asset Management Ltd ASX:PTM	AU
A	Alpha Pro Tech Ltd SWB:APL	CA
D	Dupont De Nemours Inc BMV:DD	US
C	Cheniere Energy Inc XMUN:CHQ1	US
	Austal Ltd ASX:ASB	AU
I	Industrial and Commercial Bank of China Ltd SWB:ICK	CN
	PubMatic Inc NASDAQ:PUBM	US
G	Grupa Azoty SA WSE:ATT	PL
B	Banc of California Inc SWB:FPB	US

Profitability Summary

Rigel Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

93%

Declining Gross Margin

98% > 93%

Exceptional Operating Margin

42%

Sustainable 3Y Average Operating Margin

11%

Operating Margin is Increasing

-27% > 42%

Exceptional Net Margin

122%

Sustainable 3Y Average Net Margin

21%

Net Margin is Increasing

-30% > 122%

Exceptional Free Cash Flow Margin

26%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-38% > 26%

Exceptional ROE

174%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

41%

ROIC is Increasing

-82% > 166%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.